{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:02:07Z","timestamp":1780646527435,"version":"3.54.1"},"reference-count":37,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Obstet Med"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hairy cell leukaemia (HCL) represents less 1% of all lymphoid neoplasms with cases rarely reported in pregnancy. Management of HCL requires multidisciplinary care to optimise maternal and neonatal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search of Ovid MEDLINE and EMBASE for \u2018hairy cell leukaemia\u2019 and \u2018Pregnancy\u2019 was undertaken.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thirteen cases were reviewed including three within our own institutions. Interferon-alpha was the most prominent treatment at varying doses in n\u2009=\u20093 (23%) patients. Other management included antenatal cladribine and rituximab, post-partum cladribine with and without rituximab, laparoscopic splenectomy and termination of pregnancy. 46.1% (n\u2009=\u20096) of patients birthed vaginally. Due to thrombocytopenia, there was a greater proportion of caesarean delivery under general anaesthetic and half of the cases documented bleeding complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Diagnosis and management of HCL in pregnancy is difficult. Women can be managed safely and outcome aims should be the same as non-pregnant patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1753495x251356377","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T06:45:26Z","timestamp":1755672326000},"page":"108-114","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Management of hairy cell leukaemia in pregnancy"],"prefix":"10.1177","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8660-665X","authenticated-orcid":false,"given":"Simone","family":"Da Cruz","sequence":"first","affiliation":[{"name":"Western Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"Mason","sequence":"additional","affiliation":[{"name":"Royal Melbourne Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Renwick","sequence":"additional","affiliation":[{"name":"Royal Melbourne Hospital"},{"name":"Western Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M","family":"Said","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynaecology and Newborn Health, The University of Melbourne, Parkville, Australia"},{"name":"Western Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0503-9164","authenticated-orcid":false,"given":"Briony A","family":"Cutts","sequence":"additional","affiliation":[{"name":"Western Health"},{"name":"Department of Obstetrics, Gynaecology and Newborn Health, The University of Melbourne, Parkville, Australia"},{"name":"Royal Women's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"e_1_3_2_2_2","first-page":"100236","article-title":"A population-based study of hairy cell leukemia over a period of 20 years","volume":"25","author":"Wiber M","year":"2020","unstructured":"Wiber M, Maitre E, Poncet JM, et al. A population-based study of hairy cell leukemia over a period of 20 years. Cancer Treat Res Commun 2020; 25: 100236.","journal-title":"Cancer Treat Res Commun"},{"key":"e_1_3_2_3_2","first-page":"67","article-title":"A review of hematological malignancy in pregnancy","volume":"3","author":"Sakri AAM","year":"2021","unstructured":"Sakri AAM, Nusee Z, Ahmad Mustafa AM, et al. A review of hematological malignancy in pregnancy. Eur J Med Health Sci 2021; 3: 67\u201371.","journal-title":"Eur J Med Health Sci"},{"key":"e_1_3_2_4_2","first-page":"62","article-title":"Hairy cell leukemia: a case report","volume":"43","author":"Ainoon O","year":"1988","unstructured":"Ainoon O, et al. Hairy cell leukemia: a case report. Med J Malays 1988; 43: 62\u201364.","journal-title":"Med J Malays"},{"key":"e_1_3_2_5_2","first-page":"3238168","article-title":"Hairy cell leukemia masquerading as pancytopenia in pregnancy","volume":"2019","author":"Shackleton L","year":"2019","unstructured":"Shackleton L, et al. Hairy cell leukemia masquerading as pancytopenia in pregnancy. Case Rep Hematol 2019; 2019: 3238168.","journal-title":"Case Rep Hematol"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08202.x"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2012.06.009"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/136823"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-12-199406150-00019"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(13)90471-3"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(87)90240-7"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00288-6"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1017\/9781316410837"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181c2bde8"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802897"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-023-06227-8"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2016.02.001"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26390"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-689422"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25653"},{"key":"e_1_3_2_21_2","volume-title":"Saving Lives, Improving Mothers\u2019 Care Compiled report \u2013 Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2020\u201322","author":"Felker A","year":"2024","unstructured":"Felker A, Patel R, Kotnis R, et al. (eds), on behalf of MBRRACE-UK. Saving Lives, Improving Mothers\u2019 Care Compiled report \u2013 Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2020\u201322. Oxford: National Perinatal Epidemiology Unit, University of Oxford, 2024."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","unstructured":"Datta - Datta P Ciplea AI Rewers-Felkins K et al. Cladribine transfer into human milk: a case report. Mult Scler J 2021; 27: 799\u2013801.","DOI":"10.1177\/1352458520912173"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","unstructured":"Krysko KM LaHue SC Anderson A et al. Minimal breast milk transfer of rituximab a monoclonal antibody used in neurological conditions. Neurol Neuroimmunol Neuroinflammation 2020; 7: 1\u20136.","DOI":"10.1212\/NXI.0000000000000637"},{"key":"e_1_3_2_24_2","unstructured":"Lau - Lau RJ Emery MG and Galinsky RE. Unexpected accumulation of Acyclovir in breast milk with estimation of infant exposure. Obstet Gynecol 1987; 69: 468\u2013471."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","unstructured":"Taddio A Klein J and Koren G. Acyclovir Excretion in human breast milk. Ann Pharmacother 1994; 28: 585\u2013587.","DOI":"10.1177\/106002809402800506"},{"key":"e_1_3_2_26_2","volume-title":"Medications and Mother's Milk","author":"Hale TW","unstructured":"Hale TW. Medications and Mother's Milk. 19th ed. Texas: Hale Publishing L.P., 2021."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00059-5"},{"key":"e_1_3_2_28_2","article-title":"Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series","volume":"5","author":"Perrotta K","year":"2021","unstructured":"Perrotta K, et al. Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series. Rheumatol Adv Pract 2021; 5: rkaa074.","journal-title":"Rheumatol Adv Pract"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.09.061"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.2870"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000600"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1159\/000487128"},{"key":"e_1_3_2_33_2","unstructured":"Vemurafenib. The women\u2019s pregnancy and breastfeeding medicine guide 2024. November 22 2024."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2021.02.005"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-021-01257-7"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-023-05465-0"},{"key":"e_1_3_2_37_2","unstructured":"Module 5 Obstetrics and Maternity: Patient Blood Management Guidelines. 2015."},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(21)00242-8"}],"container-title":["Obstetric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1753495X251356377","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1753495X251356377","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1753495X251356377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T07:16:24Z","timestamp":1780643784000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1753495X251356377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1177\/1753495X251356377"],"URL":"https:\/\/doi.org\/10.1177\/1753495x251356377","relation":{},"ISSN":["1753-495X","1753-4968"],"issn-type":[{"value":"1753-495X","type":"print"},{"value":"1753-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]}}}